Marketable securities
|
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2013
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marketable securities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marketable securities |
5. The carrying amounts of financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximated fair value at March 31, 2013 and December 31, 2012 because of the relative short maturity of these instruments.
There were no available-for-sale securities as of March 31, 2013.
Investments in available-for-sale securities at December 31, 2012 were:
The cost and market value of the Company’s investments at December 31, 2012 determined by contractual maturity were :
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The entire disclosure for investments in certain debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|